Showing results (131-140 of 148) with videos related to
Sort By:
Pageof 15
BMC Infectious Diseases|June 27, 2019
Clusterization of co-morbidities and multi-morbidities among persons living with HIV: a cross-sectional studyPaolo Maggi, Carmen R Santoro, Marco Nofri, et al.Antibiotics (Basel, Switzerland)|July 27, 2024
Efficacy and Safety of Ceftazidime-Avibactam Alone versus Ceftazidime-Avibactam Plus Fosfomycin for the Treatment of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia: A Multicentric Retrospective Study from the SUSANA CohortMarco Fois, Andrea De Vito, Francesca Cherchi, et al.International Journal of Antimicrobial Agents|December 6, 2014
Muscle symptoms and creatine phosphokinase elevations in patients receiving raltegravir in clinical practice: Results from the SCOLTA project long-term surveillanceGiordano Madeddu, Giuseppe V L De Socio, Elena Ricci, et al.AIDS (London, England)|February 1, 2024
People with HIV pioneers of injectable cabotegravir and rilpivirine long acting in Italy: who are they?Claudia Bartalucci, Federico Baldi, Elena Ricci, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 26, 2013
Safety and durability in a cohort of HIV-1 positive patients treated with once and twice daily darunavir-based therapy (SCOLTA Project)Barbara Menzaghi, Elena Ricci, Laura Carenzi, et al.Viruses|May 28, 2022
Reversibility of Central Nervous System Adverse Events in Course of ArtLucia Taramasso, Giancarlo Orofino, Elena Ricci, et al.Plos One|June 21, 2017
Safety and tolerability of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) projectNicola Squillace, Elena Ricci, Tiziana Quirino, et al.Journal of Molecular and Cellular Cardiology|August 18, 2018
Anti-androgenic therapy with finasteride improves cardiac function, attenuates remodeling and reverts pathologic gene-expression after myocardial infarction in miceNatali Froese, Honghui Wang, Carolin Zwadlo, et al.Plos One|July 19, 2012
96 Week follow-up of HIV-infected patients in rescue with raltegravir plus optimized backbone regimens: a multicentre Italian experienceAmedeo Capetti, Simona Landonio, Paola Meraviglia, et al.Infection and Drug Resistance|May 8, 2018
Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA ProjectPaola Bagella, Giuseppe Vl De Socio, Elena Ricci, et al.Pageof 15